In recent years, medical malpractice lawyers and healthcare providers across the United States have watched jury awards climb into territory that would have seemed unthinkable a decade ago. Verdicts over $10 million—often called “nuclear” verdicts—are no longer rare outliers but a recurring feature of the malpractice landscape.
For patients and families, these eye‑catching numbers can look like long‑overdue accountability. For physicians, hospitals, and insurers, they signal rising financial and legal risk. The American Medical Association (AMA) has gone so far as to publicly warn that these trends could push some states toward a “hard market” in medical liability insurance, echoing the crisis conditions of the early 2000s.
How Big Are Malpractice Awards Now?
One of the clearest indicators of the shift is the average size of the largest verdicts. According to data cited by the AMA and leading malpractice insurer The Doctors Company, the average of the top 50 U.S. medical malpractice verdicts has climbed sharply in just a few years:
- 2022: $32 million
- 2023: $48 million
- 2024: $56 million
This means that, among the biggest cases, the “typical” top‑tier verdict is now well into eight‑figure territory, and some awards exceed $100 million. At the same time, a report summarized by the AMA noted that in 22 states, at least 50% of reported malpractice insurance premiums increased between 2023 and 2024, reflecting how these large awards are feeding back into pricing.
It is important to remember that these figures represent the very top end of outcomes. Most malpractice claims still settle for much lower amounts, and only a small fraction go to trial at all. But the upper tail is getting heavier—and that changes expectations on both sides of the courtroom.
Why Are Verdicts Getting Larger?
Experts point to a mix of economic factors, social attitudes, and litigation strategies to explain why malpractice awards—especially the largest ones—are rising.
1. Social inflation and loss of trust
The AMA and major insurers describe a phenomenon known as social inflation, where the average claim cost rises faster than general economic inflation. Several forces are driving this:
- Erosion of public trust in healthcare after the COVID‑19 pandemic, which has made some jurors more skeptical of hospitals and large health systems.
- Corporatization and consolidation of healthcare, which can make institutional defendants look more like deep‑pocketed corporations than individual community physicians.
- Changing jury perspectives on accountability, with some jurors expressing a desire to compensate plaintiffs generously even in borderline negligence situations.
Large numbers also no longer carry the shock value they once did. As one AMA attorney noted, jurors now routinely hear about athletes signing $100‑million contracts or tech deals in the billions, so a $10 or $20 million award can feel relatively modest by comparison.
2. Legal tactics: “Reptile theory” and anchoring
The AMA has also highlighted specific plaintiffs’ attorney strategies that can push verdicts higher:
- Reptile theory: Instead of focusing only on what happened to the individual patient, the argument is framed around what could happen to the entire community if such conduct is tolerated. This taps into jurors’ basic safety and survival instincts—suggesting that a large verdict is needed to protect everyone, not just compensate one person.
- Anchoring: Plaintiffs’ lawyers sometimes request very high damage numbers, even beyond what they expect to win, to set a psychological “anchor” for the jury. Research shows that when jurors hear a high initial figure, their eventual award tends to be higher than it would have been without that anchor.
- Aggressive settlement posture (“bullying”): In some instances, lawyers emphasize threats to pursue individual physicians’ personal assets or to seek punitive damages, which can pressure insurers and providers into higher settlements to avoid the risk of a runaway verdict.
These tactics do not create negligence where none exists, but they can significantly influence how jurors translate anger and concern into dollar amounts once liability is established.
The Role of Catastrophic Injuries
Another major driver of large awards is the severity of injuries at issue. Nuclear verdicts almost always involve:
- Profound, permanent disabilities (such as severe brain injury, cerebral palsy, or locked‑in syndrome).
- Lifelong needs for 24/7 care, specialized equipment, and medical supervision.
- Lost earning capacity over decades, especially when the injured person was young at the time of the event.
In such cases, economic damages alone—covering projected medical care, support services, and lost income—can reasonably run into the tens of millions of dollars when calculated over a lifetime. On top of that, juries must assign a value to pain, suffering, and loss of enjoyment of life, which is where non‑economic damages can accelerate a verdict into nuclear territory.
From a malpractice lawyer’s perspective, these cases require intensive expert work: life‑care planners, economists, neurologists, and rehabilitation specialists often testify to show exactly how much care will cost over 30, 40, or 50 years. When the negligence appears clear and the human impact is overwhelming, jurors may feel morally compelled to award very high sums.
How Physicians and Insurers Are Responding
The surge in large verdicts has not gone unnoticed by physicians or insurers:
- A survey cited in industry reporting found that about 43% of physicians are specifically concerned about “nuclear” verdicts and say the risk has made them more cautious in their practice, though a majority report no change in day‑to‑day care.
- Insurers and actuarial studies show that the growth in large claims—especially those over $5 million—is outpacing inflation, leading to higher premiums and, in some markets, tighter underwriting standards.
Some doctors worry that this environment encourages defensive medicine—ordering more tests or referrals primarily to manage legal risk, not clinical necessity. Others argue that large verdicts are a needed counterweight to systemic problems and can drive safety improvements.
For malpractice lawyers representing patients, the trend can open the door to more realistic valuations of catastrophic cases that were previously undervalued. But it also raises the bar: defense teams are increasingly sophisticated, and courts are more sensitive to arguments that verdicts must be proportionate and grounded in evidence rather than emotion alone.
State-Level Pushback: New Limits on Trial Tactics
In response to the combination of social inflation and aggressive trial tactics, some states have begun experimenting with statutory guardrails.
For example:
- Utah and Georgia have recently passed tort‑reform measures aimed at curbing certain techniques, such as arguing specific dollar values for non‑economic damages during the liability phase of a trial or using overtly fear‑based appeals.
- Other states are revisiting damage caps or adjusting existing caps upward but with tighter rules on how non‑economic damages are argued at trial.
These reforms are politically contentious. Patient advocates and plaintiffs’ lawyers argue that strict caps and procedural limits can undercompensate seriously injured people and reduce incentives for systemic change. Physician groups and insurers counter that without constraints, runaway verdicts will threaten access to care, particularly in high‑risk specialties and rural areas.
What This Means for Patients and Medical Malpractice Lawyers
For visitors to a site like lawyersformedicalmalpractice.top, the rise in nuclear verdicts has several practical implications:
- Large verdicts are possible, but not typical. A small fraction of cases will ever resemble the top‑50 verdicts highlighted in national reports. Most malpractice claims settle out of court and for far lower amounts.
- Evidence still rules. Even in an era of higher awards, plaintiffs must still prove the classic malpractice elements: duty, breach of the standard of care, causation, and damages. No trend can substitute for strong medical expert support and a well‑documented story.
- Expect more intense litigation on both sides. As stakes rise, defense teams are more likely to challenge plaintiffs’ experts, life‑care plans, and economic projections aggressively. Plaintiffs’ lawyers, in turn, invest more heavily in jury research, demonstrative evidence, and narrative framing.
- Venue and state law matter more than ever. Differences in damage caps, jury attitudes, and recent appellate decisions mean that the same injury could produce very different outcomes in different states—or even different counties.
Ultimately, the trend toward larger malpractice awards is neither pure good nor pure bad. For some catastrophically injured patients, it represents long‑overdue recognition of what a lifetime of care truly costs. For physicians and hospitals, it is a reminder that errors in high‑stakes settings can carry consequences far beyond the immediate clinical harm.
For medical malpractice lawyers, it is a call to practice at a higher level—grounding every claim in rigorous medicine and careful economics, while speaking to juries in a way that is honest, human, and anchored in the real value of a patient’s life.
